1. A randomised double-blind placebo-controlled crossover trial of humira (adalimumab) for erosive hand osteoarthritis: the humor trial. (April 2017) Authors: Aitken, D.; Pan, F.; Laslett, L.; Bellamy, N.; Bird, P.; Haugen, I.; Jones, G. Journal: Osteoarthritis and cartilage Issue: Volume 25(2017)Supplement 1 Page Start: S9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0274 Towards imaging remission: Determining a MRI inflammatory activity acceptable state in rheumatoid arthritis. (23rd January 2014) Authors: Haavardsholm, E.A.; Gandjbakhch, F.; Conaghan, P.; Ejbjerg, B.J.; Foltz, V.; Brown, A.; Døhn, U.M.; Lassere, M.; Freeston, J.; Bøyesen, P.; Bird, P.; Fautrel, B.; Hetland, M.L.; Emery, P.; Bourgeois, P.; Hørslev-Petersen, K.; Olsen, I.C.; Østergaard, M. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SAT0476 Impact of etanercept-methotrexate therapy on patient-reported outcomes in a randomized controlled trial in moderately active rheumatoid arthritis patients. (23rd January 2014) Authors: Bird, P.; Wollenhaup, J.; Lee, S.-H.; Szekanecz, Z.; Neira, O.; Hammond, C.; Vlahos, B.; Szumski, A.; Koenig, A.S.; Kotak, S. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 633 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0241 Rheumatoid Arthritis Patients in Australian Database Show Significant Improvement in Disease Activity over 5 Years. (10th June 2014) Authors: Littlejohn, G.; Roberts, L.; Bird, P.; de Jager, J.; Griffiths, H.; Nicholls, D.; Young, J.; Zochling, J.; Tymms, K.E. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 883 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. THU0432 Apremilast, An Oral Phosphodiesterase 4 Inhibitor, Is Associated with Long-Term (104-Week) Improvement in Fatigue in Patients with Psoriatic Arthritis: Pooled Results from 3 Phase III, Randomized, Controlled Trials. (15th July 2016) Authors: Kavanaugh, A.; Gladman, D.D.; Edwards, C.J.; Poder, A.; Lioté, F.; Bird, P.; Schett, G.; Nguyen, D.; Teng, L.; Mease, P.J. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 346 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. AB0778 A longitudinal study of the clinical effects of conventional and biologic disease modifying anti-rheumatic drugs in australian rheumatology practice. (23rd January 2014) Authors: Roberts, L.; Tymms, K.; de Jager, J.; Littlejohn, G.; Griffiths, H.; Nicholls, D.; Bird, P.; Hill, J.; McCloud, P.; Zochling, J. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A1028 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SAT0389 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, is Associated with Long-Term (52-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Results from the Palace 4 Phase 3, Randomized, Controlled Trial. (10th June 2014) Authors: Edwards, C.; Wells, A.; Adebajo, A.; Kivitz, A.; Bird, P.; Shah, K.; Hu, C.; Stevens, R.M.; Aelion, J. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 735 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. THU0188 EFFICACY OF FILGOTINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH POOR PROGNOSTIC FACTORS: POST HOC ANALYSIS OF FINCH 3. (2nd June 2020) Authors: Aletaha, D.; Westhovens, R.; Gaujoux-Viala, C.; Adami, G.; Matsumoto, A.; Bird, P.; Messina, O.; Buch, M. H.; Bartok, B.; Yin, Z.; Guo, Y.; Hendrikx, T.; Burmester, G. R. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 312 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. SAT0425 NOVEL COMPUTER-ASSISTED METHODOLOGY FOR QUANTITATIVE ASSESSMENT OF MRI TREATMENT RESPONSES TO APREMILAST IN PATIENTS WITH PSORIATIC ARTHRITIS. (13th June 2020) Authors: Bird, P.; Boesen, M.; Hinton, M.; Sanverdi, E.; Hagoug, R.; Sabin, C.; Nakasato, P.; Guerette, B.; Kubassova, O. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1166 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. SAT0165 Reasons for bdmard cessation and subsequent persistence of second line treatment in a large real world rheumatoid arthritis registry. (12th June 2018) Authors: Youssef, P.; Marcal, B.; Button, P.; Truman, M.; Bird, P.; Griffiths, H.; Roberts, L.; Tymms, K.; Littlejohn, G. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 943 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗